COMPLERA

FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments

This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-

Teva sues ex-exec romantically involved with Apotex’s CEO; Pfizer bids adieu to Brazil`s Teuto

This week, Phispers brings you two tales of alleged misuse of information involving former employees

After beef, India may ban gelatin capsules; GSK, Gilead’s HIV race heats up

This week in Phispers, we bring you the latest twists in the GSK-Gilead rivalry over HIV drugs. Indi

Chemical entities SHINE in the top 10 fastest-growing drugs of 2016

Global pharmaceutical companies are increasingly focusing on the development of new biologics. In fa

Top drugs by sales revenue in 2015: Who sold the biggest blockbuster drugs?

The year 2015 has gone down in history as a record year for mergers and acquisitions in the pharmace